ropinirole: Clinical Trials

7 trials of ropinirole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 6, Unknown 1

Follow ropinirole: new trials by email Literature Review of ropinirole trials Research Report on ropinirole

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
Vitamin E, Ropinirole, Muscle cramp survey - Muscle Cramp, Cirrhosis
Phase 4CompletedVanderbilt University Medical Center312016-09-022022-10-31
A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
rasagiline mesylate, Rasagiline mesylate plus Mirapex, Rasagiline mesylate with Levodopa - Parkinson's Disease
Phase 4CompletedTeva Neuroscience, Inc.2002006-10-012011-04-12
Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
Ropinirole (Requip) - Sexual Dysfunction
Phase 4CompletedSt. Luke's-Roosevelt Hospital Center92006-06-012015-02-19
Long-term Study Of Ropinirole In Restless Legs Syndrome
Placebo, Ropinirole - Restless Legs Syndrome
Phase 4CompletedGlaxoSmithKline4042006-03-012017-03-23
Ropinirole in the Treatment of Bipolar Depression
ropinirole - Bipolar Disorder
Phase 4CompletedCambridge Health Alliance402005-09-012017-04-18
Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients
Mirapex, Requip - Parkinson Disease
Phase 4CompletedBoehringer Ingelheim2462005-01-012014-03-14
A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
ropinirole - Bipolar Disorder, Major Depressive Disorder
Phase 4UnknownSheba Medical Center602003-04-012006-06-09

Conditions studied

Bipolar Disorder (2)  ·  Depression (2)  ·  Parkinson Disease (2)  ·  Depressive Disorder, Major (1)  ·  Ejaculatory Dysfunction (1)  ·  Fibrosis (1)  ·  Lymphoma, Follicular (1)  ·  Muscle Cramp (1)  ·  Restless Legs Syndrome (1)  ·  Sexual Dysfunction, Physiological (1)

Sponsors

Boehringer Ingelheim (1)  ·  Cambridge Health Alliance (1)  ·  GlaxoSmithKline (1)  ·  Sheba Medical Center (1)  ·  St. Luke's-Roosevelt Hospital Center (1)  ·  Teva Neuroscience, Inc. (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (4)  ·  Australia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Norway (1)  ·  Portugal (1)  ·  Slovakia (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Andrew Scanga, MD (1)  ·  David J. Hellerstein, MD (1)  ·  Leon Grunhaus, MD (1)  ·  MerriKay Oleen-Burkey, PhD (1)  ·  Robert T Dunn, MD,PhD (1)

Results publications

PMID 23938061, PMID 28078162